onchocerciasis vaccine (Vaxine/Thomas Jefferson University/New York Blood Center)

N/A

Report date: 2025/06/11 20:01:15

Base Information

Drug Nameonchocerciasis vaccine (Vaxine/Thomas Jefferson University/New York Blood Center)
Drug Alias NameOv-RAL-2Ov-103
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsOnchocerciasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesAustralia and New Zealand
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesVaxine Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNew York Blood CenterVaxine Pty LtdThomas Jefferson University
Active IndicationsN/A
Inactive IndicationsOnchocerciasis

Other Information

ATC CodeN/A
Related LinksN/A